BDTX
NASDAQBlack Diamond Therapeutics
$2.28
-1.27 (-35.77%)
Institutional
78.5%
Insider
0.62%
Retail/Other
20.9%
Shares Outstanding
57.3M
Top Institutional Holders
As of May 2026| Holder | Shares | % | Change |
|---|---|---|---|
| T. Rowe Price Investment Management,Inc. | 12.9M | 22.6% | +2.2M |
| NEA Management Company, LLC | 4.4M | 7.8% | - |
| Bellevue Group AG | 2.7M | 4.8% | - |
| Vanguard Group Inc | 2.2M | 3.8% | - |
| TANG CAPITAL MANAGEMENT LLC | 2.1M | 3.6% | - |
| Dimensional Fund Advisors, Inc. | 1.3M | 2.3% | +0.4M |
| Marshall Wace Asset Management Ltd | 1.1M | 1.9% | -0.2M |
| Siren, L.L.C. | 1.0M | 1.8% | - |
| Arrowstreet Capital Limited Partnership | 1.0M | 1.8% | +0.1M |
| Jane Street Group LLC | 962K | 1.7% | +0.7M |
Insider Transactions
Last 24 months (2 insiders)
Ali Behbahani
Director
86,649 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 5,208 | $2.76 | $14,374 | 2025-12-12 | 86,649 |
Prakash Raman
Director
31,027 shares
Awards (1)
| Shares | Price | Value | Date | Remaining |
|---|---|---|---|---|
| 4,665 | $2.76 | $12,875 | 2025-12-12 | 31,027 |
Congressional Trading
STOCK Act DisclosuresNo congressional trading data available for this ticker.
Congressional trading data is sourced from STOCK Act disclosures and may not be available for all tickers.
Based on public disclosures. Reporting errors by representatives are common. Disclosure deadlines are 45 days after transaction.